Goldman Sachs’s Sanaby Health Acquisition Corp. I Class A Common Stock SANB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-19,289
Closed -$194K 6774
2022
Q2
$194K Sell
19,289
-2,865
-13% -$28.7K ﹤0.01% 5655
2022
Q1
$222K Buy
+22,154
New +$221K ﹤0.01% 5828

Other funds holding SANB

Goldman Sachs's SANB Position: Q3 2022 in Review

Goldman Sachs sold out of Sanaby Health Acquisition Corp. I Class A Common Stock (SANB) in Q3 2022, closing a stake of 19,289 shares — an estimated $194K sold.

Goldman Sachs first reported a position in SANB in Q1 2022 and held it in 2 quarters. The position peaked at $222K in Q1 2022. 61 funds tracked by Wall St. Rank hold SANB as of Q3 2022.

  • Goldman Sachs reported no remaining Sanaby Health Acquisition Corp. I Class A Common Stock position as of Q3 2022 after selling out during the quarter.
  • Goldman Sachs sold 19,289 Sanaby Health Acquisition Corp. I Class A Common Stock shares in Q3 2022, an estimated $194K.
  • Goldman Sachs first reported a position in Sanaby Health Acquisition Corp. I Class A Common Stock in Q1 2022 and held it in 2 quarters.
  • Goldman Sachs's Sanaby Health Acquisition Corp. I Class A Common Stock position peaked at $222K in Q1 2022.
  • 61 funds tracked by Wall St. Rank held Sanaby Health Acquisition Corp. I Class A Common Stock as of Q3 2022.

Based on Goldman Sachs's 13F filing for Q3 2022, filed 14 Nov 2022.